I will be posting videos on Pharmacology. About the Author/ Presenter : Dr .Yogesh Gulati is M.B.B.S, M.D (Pharmacology) from KGMC Lucknow. I have more than 15 years of Experience in Clinical medicine or Clinical Research. I have co-authored books on Pharmacology, Pharmacovigilance and Nursing.
Disclaimer:
The information in these videos or on this channel is for informational knowledge only. It should not be considered as specific to needs of a specific individual organisation or entity. This information is not the substitute of the advice and treatment by your doctor, medical specialist or pharmacist. Author of the video is not to be held liable for any discrepancy. The author or any other parties associated with the making of the videos on this channel does not assume any liability to any party for any loss or damage, that may directly or indirectly result from use of any information in the videos on this channel .
Sure, I will be conducting multiple such online sessions shortly. If you are interested, you can share your email Id. My team will share with you the notification and the invite once the session is due.......
Helped Alot! Thank you Doc!! I want to mention here is ---Apraclonidine and Brimonidine are Alpha 1 selective agonist and not Alpha 2 selective agonist!
Our domestic company supplies anti-cancer drugs- (Including formulas, raw materials, and semi-finished products). Does your company need raw materials for anti-cancer drugs? Please contact me if necessary. Thank you!
Tamoxifen here mentioned in ppt is mentioning that it reduces bone resorption and fracture risk!! It should be mentioned with respect to fertility status.
A correction- Glaucoma is an optic degradative disease that can occur in association with or without increase in optical pressure. It is a group of diseases that at the end cause optic degeneration.
